Profile data is unavailable for this security.
About the company
INOVIQ Ltd is an Australia-based biotechnology company developing diagnostics and therapeutics for cancer. The Company's commercialized products include EXO-NET exosome isolation technology for biomarker discovery and diagnostics development, and the hTERT test as an adjunct test for bladder cancer. The Company is also advancing clinical-stage diagnostics for the detection and monitoring of ovarian and breast cancers, and early-stage exosome therapeutics for solid tumors.
- Revenue in AUD (TTM)959.32k
- Net income in AUD-6.93m
- Incorporated1983
- Employees85.00
- LocationINOVIQ Ltd23 Normanby Road, Notting HillNEDLANDS 3168AustraliaAUS
- Phone+61 39548-7586
- Fax+61 89388-7559
- Websitehttps://www.inoviq.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tissue Repair Ltd | 3.02m | -4.24m | 10.88m | -- | -- | 0.7824 | -- | 3.61 | -0.0701 | -0.0701 | 0.0499 | 0.2301 | 0.1777 | -- | 60.84 | -- | -24.96 | -24.25 | -26.50 | -25.27 | -- | -- | -140.49 | -518.54 | 22.40 | -- | 0.00 | -- | 236.85 | -- | -2.43 | -- | -- | -- |
| Epsilon Healthcare Ltd | 6.13m | -6.12m | 11.67m | -- | -- | -- | -- | 1.90 | -0.0164 | -0.0164 | 0.0167 | -0.0097 | 0.462 | -- | 4.95 | -- | -46.14 | -33.37 | -156.14 | -46.46 | 52.23 | 49.34 | -99.85 | -136.16 | 0.3775 | -3.92 | 1.67 | -- | -15.81 | 3.16 | -403.56 | -- | -32.83 | -- |
| Calmer Co International Ltd | 8.03m | -3.99m | 13.76m | -- | -- | 7.12 | -- | 1.71 | -0.0015 | -0.0015 | 0.0029 | 0.0006 | 1.60 | 3.29 | 14.33 | -- | -79.73 | -109.82 | -171.17 | -197.50 | 42.49 | 41.18 | -49.69 | -128.71 | 1.22 | -11.32 | 0.5482 | -- | 88.48 | 59.99 | -7.13 | -- | 27.67 | -- |
| Firebrick Pharma Ltd | 293.42k | -2.63m | 15.85m | -- | -- | 9.09 | -- | 54.01 | -0.0126 | -0.0126 | 0.0014 | 0.0069 | 0.1386 | 0.8696 | 0.4855 | -- | -124.44 | -98.41 | -143.50 | -109.28 | 35.72 | -- | -897.84 | -5,384.55 | 4.75 | -- | 0.00 | -- | 1,920.80 | -- | -124.04 | -- | -- | -- |
| Oncosil Medical Ltd | 1.26m | -15.10m | 18.07m | 2.00 | -- | 3.13 | -- | 14.32 | -1.37 | -1.37 | 0.1148 | 0.217 | 0.182 | -- | 2.18 | -- | -217.79 | -97.54 | -382.54 | -117.83 | -78.62 | -54.05 | -1,196.80 | -1,258.41 | -- | -146.89 | 0.022 | -- | 116.34 | -15.15 | -26.74 | -- | -6.31 | -- |
| TrivarX Ltd | 1.13m | -943.23k | 30.00m | 4.00 | -- | 1.27 | -- | 26.48 | -0.0018 | -0.0018 | 0.0023 | 0.0204 | 0.0923 | -- | -- | -- | -7.68 | -33.47 | -8.32 | -37.46 | -- | -- | -83.27 | -373.85 | -- | -27.05 | 0.0132 | -- | 26.38 | 3.89 | 34.25 | -- | 6.29 | -- |
| Avecho Biotechnology Ltd | 1.38m | -3.62m | 33.06m | 29.00 | -- | 34.61 | -- | 23.95 | -0.0011 | -0.0011 | 0.0004 | 0.0003 | 0.2115 | 4.46 | 1.91 | -- | -55.49 | -61.23 | -72.92 | -73.27 | 62.27 | 55.45 | -262.41 | -382.04 | 4.53 | -8.03 | 0.0647 | -- | 139.19 | -23.20 | 9.15 | -- | -- | -- |
| Vitura Health Ltd | 124.04m | 3.28m | 36.45m | 119.00 | 10.19 | 0.7556 | 6.87 | 0.2939 | 0.0054 | 0.0054 | 0.2034 | 0.0728 | 1.69 | 16.43 | 10.46 | -- | 4.11 | 12.75 | 5.72 | 17.62 | 27.21 | 30.97 | 2.43 | 6.06 | 1.05 | 9.50 | 0.2009 | -- | 0.1341 | 298.23 | -5.35 | -- | 129.38 | -- |
| Little Green Pharma Ltd | 38.49m | 5.86m | 36.68m | -- | 6.20 | 0.4264 | 3.78 | 0.9528 | 0.0194 | 0.0194 | 0.1268 | 0.2814 | 0.4262 | 0.8199 | 14.01 | -- | 6.48 | -- | 7.09 | -- | 67.46 | -- | 15.21 | -- | 0.8728 | -4.71 | 0.0541 | -- | 43.67 | -- | 140.77 | -- | -- | -- |
| Inoviq Ltd | 959.32k | -6.93m | 46.46m | 85.00 | -- | 2.20 | -- | 48.43 | -0.0623 | -0.0623 | 0.0086 | 0.1497 | 0.0478 | 3.73 | 0.6725 | -- | -34.52 | -43.01 | -37.36 | -45.87 | 87.45 | 89.08 | -722.62 | -1,543.44 | 5.72 | -- | 0.022 | -- | 21.17 | 57.69 | -5.77 | -- | -- | -- |
| Medical Developments International Ltd | 39.06m | 94.00k | 51.26m | 68.00 | 541.67 | 0.9302 | 15.55 | 1.31 | 0.0008 | 0.0008 | 0.3469 | 0.4891 | 0.6221 | 1.06 | 5.31 | -- | 0.1497 | -16.68 | 0.1738 | -18.92 | 75.35 | 72.70 | 0.2407 | -47.08 | 3.33 | -- | 0.0349 | -- | 17.82 | 11.30 | 100.23 | -24.33 | -34.91 | -- |
| Neurizon Therapeutics Ltd | 1.88m | -16.59m | 64.04m | 52.00 | -- | 16.51 | -- | 34.03 | -0.0334 | -0.0334 | 0.0038 | 0.0056 | 0.2431 | -- | 203.57 | -- | -214.34 | -65.69 | -254.22 | -74.86 | -- | -- | -881.68 | -368.00 | -- | -- | 0.00 | -- | -- | -- | -86.45 | -- | -44.79 | -- |
Data as of Feb 16 2026. Currency figures normalised to INOVIQ Ltd's reporting currency: Australian Dollar AUD
8.76%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Merchant Funds Management Pty Ltd.as of 13 Sep 2024 | 11.67m | 8.29% |
| Netwealth Investments Ltd.as of 01 Sep 2025 | 670.39k | 0.48% |
Data from 09 Dec 2024 - 02 Feb 2026Source: FactSet Research Systems Inc.
